Synaptic Loss in Multiple Sclerosis: A Systematic Review of Human Post-mortem Studies

dc.contributor.authorMöck E. E. Amelie
dc.contributor.authorHonkonen Eveliina
dc.contributor.authorAiras Laura
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=kliiniset neurotieteet|en=Clinical Neurosciences|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.contributor.organization-code1.2.246.10.2458963.20.74845969893
dc.converis.publication-id68165639
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/68165639
dc.date.accessioned2022-10-27T12:08:21Z
dc.date.available2022-10-27T12:08:21Z
dc.description.abstract<b>Background:</b> Gray matter pathology plays a central role in the progression of multiple sclerosis (MS). The occurrence of synaptic loss appears to be important but, to date, still poorly investigated aspect of MS pathology. In this systematic review, we drew from the recent knowledge about synaptic loss in human post-mortem studies. <b>Methods:</b> We conducted a systematic search with PubMed to identify relevant publications. Publications available from15 June 2021 were taken into account. We selected human post-mortem studies that quantitatively assessed the synapse number in MS tissue. <b>Results:</b> We identified 14 relevant publications out of which 9 reported synaptic loss in at least one investigated subregion. The most commonly used synaptic marker was synaptophysin; non-etheless, we found substantial differences in the methodology and the selection of reference tissue. Investigated regions included the cortex, the hippocampus, the cerebellum, the thalamus, and the spinal cord. <b>Conclusion:</b> Synaptic loss seems to take place throughout the entire central nervous system. However, the results are inconsistent, probably due to differences in the methodology. Moreover, synaptic loss appears to be a dynamic process, and thus the nature of this pathology might be captured using <i>in vivo</i> synaptic density measurements.
dc.identifier.jour-issn1664-2295
dc.identifier.olddbid173447
dc.identifier.oldhandle10024/156541
dc.identifier.urihttps://www.utupub.fi/handle/11111/31560
dc.identifier.urnURN:NBN:fi-fe2022012710673
dc.language.isoen
dc.okm.affiliatedauthorLuoma, Amelie
dc.okm.affiliatedauthorHonkonen, Eveliina
dc.okm.affiliatedauthorAiras, Laura
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.affiliatedauthorDataimport, 2609820 PET Tutkimus
dc.okm.discipline3112 Neurosciencesen_GB
dc.okm.discipline3112 Neurotieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisher.countrySwitzerlanden_GB
dc.publisher.countrySveitsifi_FI
dc.publisher.country-codeCH
dc.relation.doi10.3389/fneur.2021.782599
dc.relation.ispartofjournalFrontiers in Neurology
dc.relation.volume12
dc.source.identifierhttps://www.utupub.fi/handle/10024/156541
dc.titleSynaptic Loss in Multiple Sclerosis: A Systematic Review of Human Post-mortem Studies
dc.year.issued2021

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
fneur-12-782599.pdf
Size:
548.96 KB
Format:
Adobe Portable Document Format
Description:
Publisher's version